glp-1 for pcos weight loss agonists and GLP-1s aren't just about weight

JAMA Netw Open Vol

For example: Ozempic and Mounjaro may be covered when prescribed for Type 2 diabetes management Wegovy may be covered to reduce the risk of cardiovascular death, heart attack, or stroke in adults with established cardiovascular disease who are overweight or obese Zepbound may be covered for moderate to severe obstructive sleep apnea in adults with obesity Coverage for these approved indications depends on your specific Part D plan's formulary

Animal trials testing injecting GLP-1 drugs into arthritic joints have also been undertaken

To explore these questions, the WashU Medicine team analyzed health data from more than 600,000 U.S

Trends in peptide drug discovery